9th Circ. Mulls Pharma Exec's Use Of Forced Arbitration Law

By Bonnie Eslinger · December 2, 2025, 9:23 PM EST

A California biopharmaceutical company told the Ninth Circuit on Tuesday that a district court erred in letting its former chief financial officer move her discrimination claims out of arbitration and into...

To view the full article, register now.

Case Information

Case Title

Ding v. Structure Therapeutics, Inc., et al.

Case Number

25-1532

Court

Appellate - 9th Circuit

Nature of Suit

Date Filed

March 10, 2025